Federation Des Caisses Desjardins Du Quebec Cyclacel Pharmaceuticals, Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $17.5 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 30, 2024
BUY
$7.59 - $10.48 $15,180 - $20,960
2,000 New
2,000 $11.8 Million
Q4 2020

Aug 30, 2024
SELL
$5.0 - $7.5 $5,000 - $7,500
-1,000 Reduced 33.33%
2,000 $15.6 Million
Q3 2020

Aug 30, 2024
BUY
$4.81 - $6.49 $4,810 - $6,490
1,000 Added 50.0%
3,000 $11 Million
Q2 2020

Aug 30, 2024
BUY
$5.2 - $7.75 $10,400 - $15,500
2,000 New
2,000 $9.3 Million

About Cyclacel Pharmaceuticals, Inc.

CYCC Quotes by TradingView
  • Ticker CYCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,539,200
  • Market Cap $7.9M
  • Description
  • Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combin...
More about CYCC
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email